NL-OMON51045
Completed
Not Applicable
Evaluation and validation of a novel blood collecting system using a finger prick for SARS-CoV-2 serology. - Ser-CoV
Streeklab Haarlem0 sites100 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Streeklab Haarlem
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Voluntary participants with an age of 18 years or older. He or she must be
- •able to read and understand the informed consent form and to independently
- •perform a capillary blood collection.
- •\- At least 1 PCR confirmed SARS\-CoV\-2 infection OR a positive result in
- •serology through venous blood collection
Exclusion Criteria
- •\- Voluntary participants under 18 years old.
- •\- Absence of PCR confirmed SARS\-CoV\-2 infection OR patients with a confirmed
- •respiratory infection with a pathogen other than SARS\-CoV\-2 OR patients with
- •negative test result for SARS\-CoV\-2 serology in venous blood collection.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of new blood collection systemsgeen enkele. De proefpersonen worden niet op aandoening geselecteerd.noneNL-OMON48834Medlon b.v.110
Recruiting
Not Applicable
Evaluation of clinical performance of a new blood coagulation test systemCardiac surgeryJPRN-UMIN000031769Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences30
Completed
Not Applicable
Validation of a novel capillairy bloodsampling kit (Demecal) for the detection of HIV antibodiesnvt10047438NL-OMON31729Demecal Europe BV (www.demecal.eu)20
Not yet recruiting
Not Applicable
Evaluation of blood collection systemsIn this study the influence of the bloodcollectionsystem on laboratory results is studied on a number of specific laboratory tests.NL-OMON20486Medlon b.v.105
Completed
Phase 1
Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive SolutionBlood DonorsNCT02145507Haemonetics Corporation170